<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-antibiotics-09-00909">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rijnders</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Wolffs</surname>
    <given-names>P.F.</given-names>
   </name>
   <name>
    <surname>Hopstaken</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>den Heyer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bruggeman</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Stobberingh</surname>
    <given-names>E.E.</given-names>
   </name>
  </person-group>
  <article-title>Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands</article-title>
  <source>J. Antimicrob Chemother</source>
  <year>2012</year>
  <volume>67</volume>
  <fpage>1176</fpage>
  <lpage>1180</lpage>
  <pub-id pub-id-type="doi">10.1093/jac/dkr590</pub-id>
  <?supplied-pmid 22290345?>
  <pub-id pub-id-type="pmid">22290345</pub-id>
 </element-citation>
</ref>
